[go: up one dir, main page]

ECSP10010622A - Composición farmacéutica que comprende una sal de estroncio, vitamina d y una ciclodextrina - Google Patents

Composición farmacéutica que comprende una sal de estroncio, vitamina d y una ciclodextrina

Info

Publication number
ECSP10010622A
ECSP10010622A EC2010010622A ECSP10010622A ECSP10010622A EC SP10010622 A ECSP10010622 A EC SP10010622A EC 2010010622 A EC2010010622 A EC 2010010622A EC SP10010622 A ECSP10010622 A EC SP10010622A EC SP10010622 A ECSP10010622 A EC SP10010622A
Authority
EC
Ecuador
Prior art keywords
vitamin
pharmaceutical composition
cyclodextrine
strontium salt
strontium
Prior art date
Application number
EC2010010622A
Other languages
English (en)
Inventor
Jean-Manuel Pean
Gilles Briault
Xavier Quenault
Cecile Poirier
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41719206&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP10010622(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of ECSP10010622A publication Critical patent/ECSP10010622A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composición farmacéutica que comprende una sal de estroncio, vitamina D y una ciclodextrina.
EC2010010622A 2009-11-27 2010-11-22 Composición farmacéutica que comprende una sal de estroncio, vitamina d y una ciclodextrina ECSP10010622A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0905706A FR2953139B1 (fr) 2009-11-27 2009-11-27 Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine

Publications (1)

Publication Number Publication Date
ECSP10010622A true ECSP10010622A (es) 2011-06-30

Family

ID=41719206

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2010010622A ECSP10010622A (es) 2009-11-27 2010-11-22 Composición farmacéutica que comprende una sal de estroncio, vitamina d y una ciclodextrina

Country Status (31)

Country Link
US (1) US20110130370A1 (es)
EP (1) EP2335704A1 (es)
JP (1) JP2011111458A (es)
KR (1) KR101278935B1 (es)
CN (1) CN102078620A (es)
AP (1) AP2010005490A0 (es)
AR (1) AR079160A1 (es)
AU (1) AU2010241527B2 (es)
BR (1) BRPI1004685A2 (es)
CA (1) CA2723119C (es)
CL (1) CL2010001260A1 (es)
CO (1) CO6280058A1 (es)
CU (1) CU20100230A7 (es)
EA (1) EA018460B1 (es)
EC (1) ECSP10010622A (es)
FR (1) FR2953139B1 (es)
GE (1) GEP20135734B (es)
HN (1) HN2010002518A (es)
IL (1) IL209348A0 (es)
MA (1) MA32363B1 (es)
MX (1) MX2010012566A (es)
MY (1) MY158261A (es)
NZ (1) NZ589513A (es)
PE (1) PE20110407A1 (es)
SG (1) SG171542A1 (es)
SV (1) SV2010003744A (es)
TW (1) TW201200136A (es)
UA (1) UA105766C2 (es)
UY (1) UY33039A (es)
WO (1) WO2011064474A1 (es)
ZA (1) ZA201008230B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3095447T (pt) 2006-02-03 2022-01-24 Opko Renal Llc Tratamento da insuficiência e deficiência de vitamina d com 25-hidroxivitamina d2 e 25-hidroxivitamina d3
SI2037936T1 (sl) 2006-06-21 2014-11-28 Opko Renal, Llc Postopek zdravljenja in prepreäśevanja sekundarnega hiperparatiroidizma
SI2481400T1 (sl) 2007-04-25 2014-11-28 Opko IP Holdings II, Inc. Nadzorovano oralno sproščanje sestavkov, ki vsebujejo spojino vitamina D in voskasti nosilec
EP2148684B1 (en) 2007-04-25 2013-01-16 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
ME02477B (me) 2009-11-27 2017-02-20 Genzyme Corp Genz 112638 za lečenje gošeove ili fabrijeve bolesti u kombinacionoj terapiji
LT2552484T (lt) 2010-03-29 2020-04-27 Opko Ireland Global Holdings, Ltd. Būdai ir kompozicijos, skirti paratiroidų lygiams sumažinti
CN102525975B (zh) * 2011-12-14 2013-06-19 天津药物研究院药业有限责任公司 雷奈酸锶口腔崩解片及其制备方法
CN102626420B (zh) * 2012-04-13 2014-06-25 深圳大学 一种含有锶、钙和维生素d的混合制剂
EP2756841B1 (en) * 2013-01-21 2015-05-13 Galenicum Health S.L. Pharmaceutical compositions comprising an acid salt
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
CN103142623B (zh) * 2013-03-21 2014-04-16 青岛正大海尔制药有限公司 骨化三醇和雷尼酸锶的混悬颗粒及其制备方法
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
JP6706799B2 (ja) * 2014-12-19 2020-06-10 国立大学法人 長崎大学 新規ビスホスホン酸誘導体及びその用途
MY198547A (en) 2016-03-28 2023-09-04 Opko Ireland Global Holdings Ltd Methods of vitamin d treatment
WO2018084959A2 (en) 2016-09-30 2018-05-11 Nelson Deanna J Pharmaceutical quality strontium l-lactate
WO2018200736A2 (en) * 2017-04-25 2018-11-01 The Buck Institute For Research On Aging Formulations for extending lifespan and healthspan
WO2019004984A2 (en) * 2017-05-29 2019-01-03 Biofarma Ilac Sanayi Ve Ticaret A.S. PHARMACEUTICAL FORMULATION COMPRISING CHOLECALCIFEROL
CN109276710A (zh) * 2018-11-23 2019-01-29 中国医学科学院药用植物研究所海南分所 一种增加骨密度的组合物及其制备方法和用途
CN112370429A (zh) * 2019-10-21 2021-02-19 广州富诺营养科技有限公司 一种直压型有机钙维生素d3咀嚼片及其制备方法
CN114452259A (zh) * 2021-07-28 2022-05-10 安徽旺盛添加剂有限公司 一种维生素d微囊钙片及其制备方法
CN119055788A (zh) * 2023-05-31 2024-12-03 葛兰素史克消费保健（美国）控股有限责任公司 活性成分络合物及其制备方法
WO2024246793A1 (en) * 2023-05-31 2024-12-05 Haleon Us Holdings Llc Active ingredient complex and method of making thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52130904A (en) * 1976-04-26 1977-11-02 Teijin Ltd Stabilization of vitamin d#
HU177586B (en) * 1978-12-19 1981-11-28 Chinoin Gyogyszer Es Vegyeszet New process for preparing stable inclusion complexes of vitamine d with cyclodextrin
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
FR2651497B1 (fr) 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
CN1110275A (zh) * 1994-04-06 1995-10-18 福建省药品检验所 一种维生素D与羟丙基-β-环糊精的包合物
FR2749759B1 (fr) 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
MXPA02004743A (es) * 1999-11-12 2003-10-14 Roquette Freres Mezclas cristalinas de eteres de metilo parciales de beta-ciclodextrina y compuestos relacionados.
EP1155043A1 (en) * 1999-12-23 2001-11-21 Cerestar Holding B.V. Stabilized cyclodextrin complexes
JP2003268005A (ja) * 2002-03-14 2003-09-25 Medorekkusu:Kk 包接体の製造法
PL2266585T3 (pl) 2003-05-07 2013-10-31 Osteologix As Rozpuszczalne w wodzie sole stronktu do stosowania w leczeniu chorób chrząstki i/lub kości
EP2266584B1 (en) 2003-05-07 2012-09-05 Osteologix A/S Composition with strontium and vitamin D for the prophylaxis and/or treatment of cartilage and/or bone conditions
US20060216358A1 (en) * 2003-05-07 2006-09-28 Christian Hansen Controlled release composition containing a strontium salt
EP1632594B1 (en) * 2003-05-30 2010-07-07 Mitsui Chemicals, Inc. Fiber for artificial hair
CA2531136A1 (en) * 2003-07-04 2005-01-13 Nycomed Danmark Aps Parathyroid hormone (pth) containing pharmaceutical compositions for oral use
WO2005123130A2 (en) * 2004-06-17 2005-12-29 Osteologix A/S Improved treatments of rheumatic and arthritic diseases comprising combinations of a 5-lipoxygenase inhibitor
US8658206B2 (en) * 2004-06-25 2014-02-25 Mokwalo SA Compositions comprising strontium and vitamin D and uses thereof
CN101018586B (zh) * 2004-06-25 2014-08-27 莫克瓦洛Spf有限公司 含锶和维生素d的组合物及其用途
US20060264497A1 (en) * 2005-03-28 2006-11-23 Zeligs Michael A Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health
DE102005017775A1 (de) * 2005-04-13 2006-10-19 Schering Ag Komplexe aus Vitamin D-Verbindungen oder deren Analoga mit einem 5Z,7E,10(19)-Trien-System und methlierten Derivaten des ß-Cyclodextrins
US20070218111A1 (en) * 2006-03-16 2007-09-20 Western Holdings, Llc Strontium compositions for bones
CN1823764A (zh) * 2006-03-27 2006-08-30 重庆医药工业研究院有限责任公司 一种含有雷奈酸锶和维生素d药物组合物
FR2899895B1 (fr) 2006-04-12 2010-09-17 Servier Lab Nouveaux sels de strontium d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR100822133B1 (ko) * 2006-11-06 2008-04-15 한미약품 주식회사 비타민 ｄ 또는 이의 유도체의 고체분산체 및비스포스포네이트를 포함하는, 골다공증 예방 또는 치료용복합제제

Also Published As

Publication number Publication date
PE20110407A1 (es) 2011-07-02
HN2010002518A (es) 2012-09-03
SV2010003744A (es) 2011-03-15
TW201200136A (en) 2012-01-01
BRPI1004685A2 (pt) 2013-03-05
KR101278935B1 (ko) 2013-06-28
CN102078620A (zh) 2011-06-01
MX2010012566A (es) 2011-05-26
CO6280058A1 (es) 2011-05-20
FR2953139A1 (fr) 2011-06-03
AR079160A1 (es) 2011-12-28
CA2723119C (fr) 2013-08-06
EP2335704A1 (fr) 2011-06-22
FR2953139B1 (fr) 2012-04-13
US20110130370A1 (en) 2011-06-02
UA105766C2 (uk) 2014-06-25
JP2011111458A (ja) 2011-06-09
AP2010005490A0 (en) 2010-12-31
UY33039A (es) 2011-04-29
ZA201008230B (en) 2011-07-27
EA018460B1 (ru) 2013-08-30
AU2010241527A1 (en) 2011-06-16
GEP20135734B (en) 2013-01-25
CL2010001260A1 (es) 2012-02-17
EA201001710A3 (ru) 2011-08-30
NZ589513A (en) 2012-06-29
AU2010241527B2 (en) 2013-12-19
SG171542A1 (en) 2011-06-29
IL209348A0 (en) 2011-02-28
KR20110059546A (ko) 2011-06-02
CU20100230A7 (es) 2012-06-29
MA32363B1 (fr) 2011-06-01
MY158261A (en) 2016-09-30
EA201001710A2 (ru) 2011-06-30
CA2723119A1 (fr) 2011-05-27
WO2011064474A1 (fr) 2011-06-03

Similar Documents

Publication Publication Date Title
ECSP10010622A (es) Composición farmacéutica que comprende una sal de estroncio, vitamina d y una ciclodextrina
ES2571041T3 (es) Composiciones antimicrobianas
BRPI1010768A2 (pt) composto, e, composição farmacêutica.
PH12012500948A1 (en) Oral compositions containing extracts of garcinia mangostana l. and related methods
GT201200284A (es) Composición farmacéutica
HRP20160807T1 (hr) Visoko koncentrirane farmaceutske formulacije koje sadrže protutijelo anti-cd20
CL2012002979A1 (es) Derivados de n3-sustituido-n1-sulfonil-5-fluorpirimidinona.
CL2011000482S1 (es) Aplicador para cuidado oral.
WO2012009723A8 (en) C-met modulator pharmaceutical compositions
MX357677B (es) Composiciones inyectables de melfalán que comprenden un derivado de ciclodextrina y métodos de fabricación y uso de las mismas.
BR112012000530A8 (pt) uso de uma população de nanopartículas metálicas, e, composição farmacêutica.
AR093645A1 (es) Una formulacion estabilizada de pemetrexed
CO7160079A2 (es) Composiciones líquidas de racecadotrillo
MX2013006644A (es) Formulacion farmaceutica novedosa que comprende nsaid y ciclodextrina.
EP3067395A4 (en) Ultraviolet radiation-curable composition, and recorded matter
CL2009001973S1 (es) Mostrador.
UA112760C2 (uk) Теобромін у комбінації з гвайфенезином для лікування кашлю
PA8846401A1 (es) Sinergismo antibiótico
CY1118277T1 (el) Σταθερη φαρμακοτεχνικη μορφη πεξιγανανης
EA201071412A1 (ru) Дронедарон для предотвращения кардиоверсии
BR112013015701A2 (pt) derivado de sulfeto difelina, medicamento e composição farmacêutica contendo o referido derivado
CL2009000054S1 (es) Frasco para cosmeticos.
CL2009000055S1 (es) Frasco para cosmeticos.
HN2009003408A (es) Inhibicion de arni de expresion de alfa-enac
MY169279A (en) A medicinal composition